{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:03:44Z","timestamp":1793703824781,"version":"4.5.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AG024904"],"award-info":[{"award-number":["U19AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015595","name":"GHR Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007333","name":"Alzheimer's Disease Neuroimaging Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007333","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007259","name":"Stony Brook University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.tjpad.2025.100252","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T15:25:51Z","timestamp":1750433151000},"page":"100252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Plasma p-tau217 predicting brain-wide tau accumulation in preclinical AD"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3026-2875","authenticated-orcid":false,"given":"Hasom","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1998-8461","authenticated-orcid":false,"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10284","key":"10.1016\/j.tjpad.2025.100252_bib0001","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet North Am Ed"},{"issue":"8","key":"10.1016\/j.tjpad.2025.100252_bib0002","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: alzheimer's Association Workgroup","volume":"20","author":"Jack Jr","year":"2024","journal-title":"Alzheimer's Dementia"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100252_bib0003","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","article-title":"Imaging the evolution and pathophysiology of Alzheimer disease","volume":"19","author":"Jagust","year":"2018","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100252_bib0004","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer's Dementia"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100252_bib0005","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41582-024-00942-2","article-title":"Biomarker-based staging of Alzheimer disease: rationale and clinical applications","volume":"20","author":"Therriault","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100252_bib0006","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer's disease: towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100252_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-023-02570-4","article-title":"Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults","volume":"146","author":"Yu","year":"2023","journal-title":"Acta Neuropathol"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100252_bib0008","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","article-title":"Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study","volume":"20","author":"Thijssen","year":"2021","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100252_bib0009","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012513","article-title":"Associations of fully automated CSF and novel plasma biomarkers with Alzheimer disease neuropathology at autopsy","volume":"97","author":"Grothe","year":"2021","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.tjpad.2025.100252_bib0010","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1093\/brain\/awac175","article-title":"Ante-mortem plasma phosphorylated tau (181) predicts Alzheimer\u2019s disease neuropathology and regional tau at autopsy","volume":"145","author":"Morrison","year":"2022","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100252_bib0011","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/jamaneurol.2021.2293","article-title":"Comparison of plasma phosphorylated tau species with amyloid and tau positron emission tomography, neurodegeneration, vascular pathology, and cognitive outcomes","volume":"78","author":"Mielke","year":"2021","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100252_bib0012","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1038\/s41467-024-46603-2","article-title":"A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings","volume":"15","author":"Brum","year":"2024","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.tjpad.2025.100252_bib0013","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100252_bib0014","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1002\/alz.14315","article-title":"Head-to-head comparison of leading blood tests for Alzheimer's disease pathology","volume":"20","author":"Schindler","year":"2024","journal-title":"Alzheimer's Dementia"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100252_bib0015","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41591-024-02869-z","article-title":"Highly accurate blood test for Alzheimer\u2019s disease is similar or superior to clinical cerebrospinal fluid tests","volume":"30","author":"Barth\u00e9lemy","year":"2024","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100252_bib0016","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1002\/alz.13026","article-title":"Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease","volume":"19","author":"Therriault","year":"2023","journal-title":"Alzheimer's Dementia"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100252_bib0017","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s00415-023-12148-5","article-title":"Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort","volume":"271","author":"Mendes","year":"2024","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100252_bib0018","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100252_bib0019","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"Van Dyck","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100252_bib0020","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","article-title":"Trial of solanezumab in preclinical Alzheimer\u2019s disease","volume":"389","author":"Sperling","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tjpad.2025.100252_bib0021","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14073","article-title":"Plasma pTau217 ratio predicts continuous regional brain tau accumulation in amyloid-positive early Alzheimer's disease","author":"Devanarayan","year":"2024","journal-title":"Alzheimer's Dementia"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100252_bib0022","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/brain\/awx320","article-title":"Widespread brain tau and its association with ageing, Braak stage and Alzheimer\u2019s dementia","volume":"141","author":"Lowe","year":"2018","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100252_bib0023","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","article-title":"New insights into atypical Alzheimer's disease in the era of biomarkers","volume":"20","author":"Graff-Radford","year":"2021","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100252_bib0024","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100252_bib0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100252_bib0026","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ana.26813","article-title":"Regional tau deposition reflects different pathways of subsequent neurodegeneration and memory decline in cognitively normal older adults","volume":"95","author":"Chen","year":"2024","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100252_bib0027","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jalz.2019.08.201","article-title":"Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease","volume":"16","author":"Ossenkoppele","year":"2020","journal-title":"Alzheimer's Dementia"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100252_bib0028","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.tjpad.2025.100252_bib0029","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neurobiolaging.2024.10.004","article-title":"Longitudinal relationships between a\u03b2 and tau to executive function and memory in cognitively normal older adults","volume":"145","author":"Chen","year":"2025","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100252_bib0030","article-title":"Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to Alzheimer's disease","volume":"7","author":"Tissot","year":"2021","journal-title":"Alzheimer's Dementia: Translat Res Clin Interv"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100252_bib0031","article-title":"Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer's continuum. Alzheimer's & Dementia: diagnosis","volume":"14","author":"Dor\u00e9","year":"2022","journal-title":"Assessment Disease Monitor"},{"issue":"10","key":"10.1016\/j.tjpad.2025.100252_bib0032","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1002\/alz.13393","article-title":"Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals","volume":"19","author":"Ferreira","year":"2023","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.tjpad.2025.100252_bib0033","first-page":"102","article-title":"Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer\u2019s pathology","author":"Therriault","year":"2024","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100252_bib0034","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jamaneurol.2022.4485","article-title":"Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography","volume":"80","author":"Therriault","year":"2023","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100252_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13195-023-01302-w","article-title":"Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment","volume":"15","author":"Mundada","year":"2023","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100252_bib0036","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100252_bib0037","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamaneurol.2020.4201","article-title":"Associations of plasma phospho-tau217 levels with tau positron emission tomography in early Alzheimer disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100252_bib0038","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1093\/brain\/awab163","article-title":"Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100252_bib0039","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamaneurol.2021.4654","article-title":"Biomarker-based prediction of longitudinal tau positron emission tomography in Alzheimer disease","volume":"79","author":"Leuzy","year":"2022","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100252_bib0040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaneurol.2020.0387","article-title":"Association of factors with elevated amyloid burden in clinically normal older individuals","volume":"77","author":"Sperling","year":"2020","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100252_bib0041","doi-asserted-by":"crossref","first-page":"802","DOI":"10.14283\/jpad.2024.122","article-title":"Amyloid and tau prediction of cognitive and functional decline in unimpaired older individuals: longitudinal data from the A4 and LEARN studies","volume":"11","author":"Sperling","year":"2024","journal-title":"J Prev Alzheimers Dis"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100252_bib0042","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.23908","article-title":"Comparing positron emission tomography imaging and cerebrospinal fluid measurements of \u03b2-amyloid","volume":"74","author":"Landau","year":"2013","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100252_bib0043","doi-asserted-by":"crossref","first-page":"823","DOI":"10.14283\/jpad.2024.134","article-title":"Longitudinal phospho-tau217 predicts amyloid positron emission tomography in asymptomatic Alzheimer's disease","volume":"11","author":"Rissman","year":"2024","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100252_bib0044","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13195-024-01513-9","article-title":"Diagnostic performance of plasma pTau217, pTau181, A\u03b21-42 and A\u03b21-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease","volume":"16","author":"Arranz","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100252_bib0045","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14264","article-title":"ADNI Biomarker Core: a review of progress since 2004 and future challenges","volume":"21","author":"Shaw","year":"2025","journal-title":"Alzheimer's Dementia"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100252_bib0046","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2967\/jnumed.116.175273","article-title":"Reference tissue\u2013based kinetic evaluation of 18F-AV-1451 for tau imaging","volume":"58","author":"Baker","year":"2017","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100252_bib0047","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","article-title":"Defining imaging biomarker cut points for brain aging and Alzheimer's disease","volume":"13","author":"Jack Jr","year":"2017","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.tjpad.2025.100252_bib0048","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.neuroimage.2017.05.058","article-title":"Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease","volume":"157","author":"Maass","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.tjpad.2025.100252_bib0049","article-title":"Tau-positron emission tomography correlates with neuropathology findings","author":"Lowe","year":"2019","journal-title":"Alzheimer's & Dementia"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100252_bib0050","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/brain\/awaa276","article-title":"18F-flortaucipir PET to autopsy comparisons in Alzheimer\u2019s disease and other neurodegenerative diseases","volume":"143","author":"Soleimani-Meigooni","year":"2020","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100252_bib0051","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00401-024-02801-2","article-title":"Association of in vivo retention of [18f] flortaucipir pet with tau neuropathology in corresponding brain regions","volume":"148","author":"Freiburghaus","year":"2024","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100252_bib0052","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114022","article-title":"Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau","volume":"13","author":"Mattsson-Carlgren","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100252_bib0053","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jamaneurol.2024.2619","article-title":"Plasma phosphorylated tau 217 and A\u03b242\/40 to predict early brain a\u03b2 accumulation in people without cognitive impairment","volume":"81","author":"Janelidze","year":"2024","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100252_bib0054","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET imaging of tau deposition in the aging human brain","volume":"89","author":"Sch\u00f6ll","year":"2016","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100252_bib0055","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s43587-022-00204-0","article-title":"Biomarker modeling of Alzheimer\u2019s disease using PET-based Braak staging","volume":"2","author":"Therriault","year":"2022","journal-title":"Nature Aging"},{"key":"10.1016\/j.tjpad.2025.100252_bib0056","article-title":"Identification of late-stage tau accumulation using plasma phospho-tau217","volume":"109","author":"Woo","year":"2024","journal-title":"EBio Medic"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100252_bib0057","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/brain\/awad042","article-title":"Predicting amyloid PET and tau PET stages with plasma biomarkers","volume":"146","author":"Jack Jr","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.tjpad.2025.100252_bib0058","article-title":"A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests","author":"Warmenhoven","year":"2024","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100252_bib0059","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/alz.12749","article-title":"Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain","volume":"19","author":"Moloney","year":"2023","journal-title":"Alzheimer's Dementia"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100252_bib0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13195-022-01005-8","article-title":"Diagnostic and prognostic performance to detect Alzheimer\u2019s disease and clinical progression of a novel assay for plasma p-tau217","volume":"14","author":"Groot","year":"2022","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100252_bib0061","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/brain\/awac333","article-title":"Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer\u2019s disease","volume":"146","author":"Janelidze","year":"2023","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100252_bib0062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","article-title":"The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET","volume":"11","author":"Klunk","year":"2015","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.tjpad.2025.100252_bib0063","article-title":"Positron emission tomography harmonization in the Alzheimer's Disease Neuroimaging Initiative: a scalable and rigorous approach to multisite amyloid and tau quantification","author":"Landau","year":"2024","journal-title":"Alzheimer's Dementia"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100252_bib0064","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","article-title":"Four distinct trajectories of tau deposition identified in Alzheimer\u2019s disease","volume":"27","author":"Vogel","year":"2021","journal-title":"Nat Med"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725001955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725001955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T17:55:02Z","timestamp":1753293302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725001955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2274580725001955"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100252","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma p-tau217 predicting brain-wide tau accumulation in preclinical AD","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100252"}}